Literature DB >> 19720831

Hepatocyte growth factor family negatively regulates hepatic gluconeogenesis via induction of orphan nuclear receptor small heterodimer partner in primary hepatocytes.

Dipanjan Chanda1, Tiangang Li, Kwang-Hoon Song, Yong-Hoon Kim, Jeonggu Sim, Chul Ho Lee, John Y L Chiang, Hueng-Sik Choi.   

Abstract

Hepatic gluconeogenesis is tightly balanced by opposing stimulatory (glucagon) and inhibitory (insulin) signaling pathways. Hepatocyte growth factor (HGF) is a pleiotropic growth factor that mediates diverse biological processes. In this study, we investigated the effect of HGF and its family member, macrophage-stimulating factor (MSP), on hepatic gluconeogenesis in primary hepatocytes. HGF and MSP significantly repressed expression of the key hepatic gluconeogenic enzyme genes, phosphoenolpyruvate carboxykinase (PEPCK), and glucose-6-phosphatase (Glc-6-Pase) and reduced glucose production. HGF and MSP activated small heterodimer partner (SHP) gene promoter and induced SHP mRNA and protein levels, and the effect of HGF and MSP on SHP gene expression was demonstrated to be mediated via activation of the AMP-activated protein kinase (AMPK) signaling pathway. We demonstrated that upstream stimulatory factor-1 (USF-1) specifically mediated HGF effect on SHP gene expression, and inhibition of USF-1 by dominant negative USF-1 significantly abrogated HGF-mediated activation of the SHP promoter. Elucidation of the mechanism showed that USF-1 bound to E-box-1 in the SHP promoter, and HGF increased USF-1 DNA binding on the SHP promoter via AMPK and DNA-dependent protein kinase-mediated pathways. Adenoviral overexpression of USF-1 significantly repressed PEPCK and Glc-6-Pase gene expression and reduced glucose production. Knockdown of endogenous SHP expression significantly reversed this effect. Finally, knockdown of SHP or inhibition of AMPK signaling reversed the ability of HGF to suppress hepatocyte nuclear factor 4alpha-mediated up-regulation of PEPCK and Glc-6-Pase gene expression along with the HGF- and MSP-mediated suppression of gluconeogenesis. Overall, our results suggest a novel signaling pathway through HGF/AMPK/USF-1/SHP to inhibit hepatic gluconeogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19720831      PMCID: PMC2781394          DOI: 10.1074/jbc.M109.022244

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Clinical significance of circulating hepatocyte growth factor, a new risk marker of carotid atherosclerosis in patients with Type 2 diabetes.

Authors:  K Satani; H Konya; T Hamaguchi; A Umehara; T Katsuno; T Ishikawa; K Kohri; Y Hasegawa; A Suehiro; E Kakishita; M Namba
Journal:  Diabet Med       Date:  2006-06       Impact factor: 4.359

2.  p38 Mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis.

Authors:  Wenhong Cao; Qu Fan Collins; Thomas C Becker; Jacques Robidoux; Edgar G Lupo; Yan Xiong; Kiefer W Daniel; Lisa Floering; Sheila Collins
Journal:  J Biol Chem       Date:  2005-11-03       Impact factor: 5.157

3.  Hepatocyte growth factor regulates E box-dependent plasminogen activator inhibitor type 1 gene expression in HepG2 liver cells.

Authors:  Shogo Imagawa; Satoshi Fujii; Jie Dong; Tomoo Furumoto; Takeaki Kaneko; Tarikuz Zaman; Yuki Satoh; Hiroyuki Tsutsui; Burton E Sobel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-08-10       Impact factor: 8.311

Review 4.  Transcriptional regulation of metabolism.

Authors:  Béatrice Desvergne; Liliane Michalik; Walter Wahli
Journal:  Physiol Rev       Date:  2006-04       Impact factor: 37.312

Review 5.  Molecular basis of endocrine regulation by orphan nuclear receptor Small Heterodimer Partner.

Authors:  Dipanjan Chanda; Jeong-Hoh Park; Hueng-Sik Choi
Journal:  Endocr J       Date:  2007-11-02       Impact factor: 2.349

6.  Hepatocyte growth factor signaling pathway inhibits cholesterol 7alpha-hydroxylase and bile acid synthesis in human hepatocytes.

Authors:  Kwang-Hoon Song; Ewa Ellis; Stephen Strom; John Y L Chiang
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

Review 7.  Structure and function of the atypical orphan nuclear receptor small heterodimer partner.

Authors:  Yong-Soo Lee; Dipanjan Chanda; Jeonggu Sim; Yun-Yong Park; Hueng-Sik Choi
Journal:  Int Rev Cytol       Date:  2007

8.  Sodium arsenite induces orphan nuclear receptor SHP gene expression via AMP-activated protein kinase to inhibit gluconeogenic enzyme gene expression.

Authors:  Dipanjan Chanda; Sung-Jin Kim; In-Kyu Lee; Minho Shong; Hueng-Sik Choi
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-27       Impact factor: 4.310

9.  Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.

Authors:  Yong Deuk Kim; Keun-Gyu Park; Yong-Soo Lee; Yun-Yong Park; Don-Kyu Kim; Balachandar Nedumaran; Won Gu Jang; Won-Jea Cho; Joohun Ha; In-Kyu Lee; Chul-Ho Lee; Hueng-Sik Choi
Journal:  Diabetes       Date:  2007-10-01       Impact factor: 9.461

10.  Glucose increases hepatic lipase expression in HepG2 liver cells through upregulation of upstream stimulatory factors 1 and 2.

Authors:  D van Deursen; H Jansen; A J M Verhoeven
Journal:  Diabetologia       Date:  2008-08-30       Impact factor: 10.122

View more
  33 in total

1.  Two polymorphisms of USF1 gene (-202G>A and -844C>T) may be associated with hepatocellular carcinoma susceptibility based on a case-control study in Chinese Han population.

Authors:  Xu Zhou; Hua-qiang Zhu; Chao-qun Ma; Hong-guang Li; Fang-feng Liu; Hong Chang; Jun Lu
Journal:  Med Oncol       Date:  2014-11-01       Impact factor: 3.064

Review 2.  Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system.

Authors:  Bram Stynen; Hélène Tournu; Jan Tavernier; Patrick Van Dijck
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

Review 3.  Role of nuclear receptor SHP in metabolism and cancer.

Authors:  Yuxia Zhang; Curt H Hagedorn; Li Wang
Journal:  Biochim Biophys Acta       Date:  2010-10-20

4.  SHP limits TLR signaling, an inducible transcriptional corepressor.

Authors:  Jiyan Zhang; Beifen Shen
Journal:  Cell Mol Immunol       Date:  2011-08-22       Impact factor: 11.530

5.  The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors.

Authors:  Jae-Min Yuk; Dong-Min Shin; Hye-Mi Lee; Jwa-Jin Kim; Sun-Woong Kim; Hyo Sun Jin; Chul-Su Yang; Kyeong Ah Park; Dipanjan Chanda; Don-Kyu Kim; Song Mei Huang; Sang Ki Lee; Chul-Ho Lee; Jin-Man Kim; Chang-Hwa Song; Soo Young Lee; Gang Min Hur; David D Moore; Hueng-Sik Choi; Eun-Kyeong Jo
Journal:  Nat Immunol       Date:  2011-07-03       Impact factor: 25.606

6.  Salidroside ameliorates insulin resistance through activation of a mitochondria-associated AMPK/PI3K/Akt/GSK3β pathway.

Authors:  Tao Zheng; Xiaoyan Yang; Dan Wu; Shasha Xing; Fang Bian; Wenjing Li; Jiangyang Chi; Xiangli Bai; Guangjie Wu; Xiaoqian Chen; Yonghui Zhang; Si Jin
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

7.  AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner.

Authors:  Ji-Min Lee; Woo-Young Seo; Kwang-Hoon Song; Dipanjan Chanda; Yong Deuk Kim; Don-Kyu Kim; Min-Woo Lee; Dongryeol Ryu; Yong-Hoon Kim; Jung-Ran Noh; Chul-Ho Lee; John Y L Chiang; Seung-Hoi Koo; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2010-08-05       Impact factor: 5.157

8.  Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models.

Authors:  Y D Kim; Y H Kim; Y M Cho; D K Kim; S W Ahn; J M Lee; D Chanda; M Shong; C H Lee; H S Choi
Journal:  Diabetologia       Date:  2012-02-21       Impact factor: 10.122

9.  Transcriptional corepressor SHP recruits SIRT1 histone deacetylase to inhibit LRH-1 transactivation.

Authors:  Dipanjan Chanda; Yuan-Bin Xie; Hueng-Sik Choi
Journal:  Nucleic Acids Res       Date:  2010-04-07       Impact factor: 16.971

10.  Phosphoenolpyruvate carboxykinase and glucose-6-phosphatase are required for steroidogenesis in testicular Leydig cells.

Authors:  Seung Won Ahn; Gil-Tae Gang; Surendar Tadi; Balachandar Nedumaran; Yong Deuk Kim; Ji Hoon Park; Gi Ryang Kweon; Seung-Hoi Koo; Keesook Lee; Ryun-Sup Ahn; Yong-Hyeon Yim; Chul-Ho Lee; Robert A Harris; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2012-10-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.